UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Journal of clinical oncology, 2015-08, Vol.33 (23), p.2516-2522

2015

Volltextzugriff (PDF)

Beyond Antibodies: The DARPin® Drug Platform

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-08, Vol.34 (4), p.423-433

2020

Volltextzugriff (PDF)

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

Blood, 2015-08, Vol.126 (7), p.851-857

2015

Volltextzugriff (PDF)

Beyond Antibodies: The DARPin® Drug Platform

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-08, Vol.34 (4), p.423-433

2020

Volltextzugriff (PDF)

Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study

British journal of haematology, 2019-02, Vol.184 (4), p.660-663

2019

Volltextzugriff (PDF)

The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies

Blood, 2009-04, Vol.113 (14), p.3276-3286

2009

Volltextzugriff (PDF)

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2021-01, Vol.39 (2), p.145-154

2021

Volltextzugriff (PDF)

Mobile Diabetes Telemedicine Clinics for Aboriginal First Nation People With Reported Diabetes in British Columbia

Canadian journal of diabetes, 2021-02, Vol.45 (1), p.89-95

2021

Volltextzugriff (PDF)

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry

PloS one, 2022-01, Vol.17 (1), p.e0262151-e0262151

2022

Volltextzugriff (PDF)

Type 2 Diabetes Mellitus Management in Canada: Is It Improving?

Canadian journal of diabetes, 2013-04, Vol.37 (2), p.82-89

2013

Volltextzugriff (PDF)

Deprescribing initiative of NSAIDs (DIN): Pharmacist-led interventions for pain management in a federal correctional setting

Canadian pharmacists journal, 2023-03, Vol.156 (2), p.85-93

2023

Volltextzugriff (PDF)

Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era

British journal of haematology, 2016-03, Vol.172 (5), p.724-734

2016

Volltextzugriff (PDF)

MP0250, a VEGF and HGF neutralizing DARPin ® molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models

Oncotarget, 2017-11, Vol.8 (58), p.98371-98383

2017

Volltextzugriff (PDF)

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada

Canadian journal of cardiology, 2010-06, Vol.26 (6), p.297-302

2010

Volltextzugriff (PDF)

The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells

Cancer immunology research, 2024-07, Vol.12 (7), p.921-943

2024

Volltextzugriff (PDF)

Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy

Canadian journal of ophthalmology, 2017-11, Vol.52, p.S45-S74

2017

Volltextzugriff (PDF)

[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice

Leukemia & lymphoma, 2017-04, Vol.58 (4), p.809-815

2017

Volltextzugriff (PDF)

A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer After Prior Trastuzumab and Pertuzumab

JCO precision oncology, 2022-11 (6)

2022

Volltextzugriff (PDF)

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States

Leukemia & lymphoma, 2015-05, Vol.56 (5), p.1295-1302

2015

Volltextzugriff (PDF)

Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy

Canadian journal of ophthalmology, 2012-04, Vol.47 (2), p.S1-S30

2012

Volltextzugriff (PDF)

The Economic Cost of Diabetes in Canada, 1998

Diabetes care, 2002-08, Vol.25 (8), p.1303-1307

2002

Volltextzugriff (PDF)

Maintenance rituximab in Veterans with follicular lymphoma

Cancer medicine (Malden, MA), 2020-10, Vol.9 (20), p.7537-7547

2020

Volltextzugriff (PDF)

Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy

Transplantation, 2008-05, Vol.85 (10), p.1400-1405

2008

Volltextzugriff (PDF)

Agreement of Point-of-Care Capillary Glycated Hemoglobin Levels with Conventional Screening Tests for Diabetes Mellitus in a Canadian First Nations Population

Canadian journal of diabetes, 2016-06, Vol.40 (3), p.242-246

2016

Volltextzugriff (PDF)

1 – 25 von 618

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(530)
Mit Volltextzugriff
(508)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(616)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(322)
Life Sciences & Biomedicine
(281)
Humans
(217)
Male
(132)
Female
(120)
Biological And Medical Sciences
(87)
Adult
(81)
Animals
(65)
Medical Sciences
(61)
Middle Aged
(61)
Aged
(55)
Neurosciences
(40)
Mice
(36)
Neurosciences & Neurology
(36)
Physical Sciences
(30)
Fundamental And Applied Biological Sciences. Psychology
(27)
United States
(26)
Aged, 80 And Over
(25)
Biochemistry & Molecular Biology
(25)
Oncology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Beyond Antibodies: The DARPin® Drug Platform

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

Beyond Antibodies: The DARPin® Drug Platform

Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study

The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors

Mobile Diabetes Telemedicine Clinics for Aboriginal First Nation People With Reported Diabetes in British Columbia

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry

Type 2 Diabetes Mellitus Management in Canada: Is It Improving?

Deprescribing initiative of NSAIDs (DIN): Pharmacist-led interventions for pain management in a federal correctional setting

Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era

MP0250, a VEGF and HGF neutralizing DARPin ® molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models

Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada

The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells

Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy

[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice

A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer After Prior Trastuzumab and Pertuzumab

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States

Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy

The Economic Cost of Diabetes in Canada, 1998

Maintenance rituximab in Veterans with follicular lymphoma

Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy

Agreement of Point-of-Care Capillary Glycated Hemoglobin Levels with Conventional Screening Tests for Diabetes Mellitus in a Canadian First Nations Population

Suchergebnisse filtern